Table 2.
Placebo | Alendronate | |||
---|---|---|---|---|
Lower compliance | High compliance | Lower compliance | High compliance | |
Total hip | −0.58a,b | −0.43a | −0.30a | 0.99 |
Femoral neck | −0.30a,c | −0.16a | −0.05a | 1.15 |
Spine | 0.49a,c | 0.48a | 0.79a | 2.33 |
Note: Results are adjusted for age, baseline BMD, height, BMI, self-reported health, smoking status, calcium intake, calcium supplement use, having a broken bone after age 45, and having a vertebral fracture at baseline.
p < .0001 compared with alendronate high-compliance group.
abp = .04 compared with placebo high-compliance group.
bcp = NS compared with placebo high-compliance group.